The Root Room is Root to Rx's story track, where recurring characters work through each issue's evidence. New here? Subscribe to the Plain Talk newsletter at RootToRx.com.

Missed the Plain Talk track? Read here.

The Oncologist's Office

The waiting room smelled like carpet cleaner and recycled air.

3 chairs pulled together near the window. Debby on the left, Maria in the middle with her coat still on, her hands folded in her lap, and Cora on the right. The receptionist had called Maria's name 45 minutes ago for her appointment and she was now back with her friends.

"He said the CBC looks good," Maria said. "Counts are moving in the right direction. 3 weeks in and it's already working."

Debby nodded, her hands on her bag clutched to her stomach. "I've been reading about the trial," Debby said. "The one that stopped early. I want you to understand why that's actually not a problem, it's a specific design feature, there's a committee called a DSMB that—"

"Deb." Maria's voice wasn't sharp. It was the voice she used when she was saying something twice.

Debby stopped, confused why the facts weren't landing.

Cora had not said anything since they sat down. She had not said much in Issue 007 either, when Sam and Rooty were going through the evidence with Debby in the kitchen. She had listened. She had let it go as long as she thought it would help.

It had helped some. Not all the way.

"She already knows about the DSMB," Cora said. She said it quietly, toward Debby, not toward Maria. "She asked me about it last week. I told her what you told me. She talked to her oncologist. She's okay with her Gleevec treatment and seeing the improvement today just validates that choice."

Debby looked at Maria. "You are?"

"I am," Maria said. "I was scared at first that the trial stopping meant they didn't have enough proof, but Dr. Reyes explained it. The evidence was too clear to keep giving people the worse drug. That's what stopping for efficacy means." She almost smiled.

Debby sat back. "Then what does she need?" Debby asked Cora.

Cora thought about it. "Maria, correct me if I'm wrong, but she needs you to ask her what she's still wondering about," she said. "Not tell her. Ask her."

Debby looked at Maria. "What are you still wondering about?"

Maria was quiet for a moment. "What happens if it stops working," she said. "Dr. Reyes mentioned something called resistance. A mutation. T-something, something about gates. He said it's not common but it happens. He said there are other drugs. But I didn't quite follow it."

Debby opened her mouth. She knew the answer. She had read the section on T315I the night before. She knew about asciminib and the myristoyl pocket. She had it ready.

Debby looked at Cora. Cora shook her head. Just slightly. Debby closed her mouth.

"That's a really good question," Debby said. "What did Dr. Reyes say it was called?"

"The gatekeeper mutation," Maria said.

"Okay," Debby said. "Do you want to look it up together? Or would it help more to write down the question and bring it to your next appointment?"

Maria thought about it. "Write it down. He's better at explaining it than the internet."

Debby found a pen. Cora reached into her bag and set a small card on Maria's knee. She did not announce it. She set it the way you set something down that belongs somewhere.

"There's a framework I use," she said. "For hard conversations. You had most of it right, Deb. You PAUSEd. You came because you care. You tried to understand what Maria was feeling." She paused. "But S is search together. Not arrive with the answer. And E is evaluate together. With the person who actually has the information."

She tapped the card. "You just did both."

Maria picked up the card. Looked at it. P. A. U. S. E.

"Take as directed by the evidence," she read off the bottom. She looked at Debby. "That's yours."

"That's all of ours," Debby said.

A door at the end of the hall opened. A nurse came through with a folder, scanning the room. She had been passing in and out for the last 20 minutes. Long enough to hear.

She paused near the chairs. "I overheard," she said, with a caring expression. She looked at Maria. "What you heard about the gatekeeper mutation is real. It also doesn't happen to most people. And if it ever did, there are newer medications that address it specifically."

The name tag said Nani. Registered Nurse. Clinical Trial Coordinator. She already knew what the room needed. She wasn't in a hurry. That was the first thing you noticed.

She glanced toward the hallway. "We also do clinical research here. Which means if the day ever came where you needed another option, some of the latest trials would be available to you, right here, as something to consider."

She did not make it a speech. She said it the way someone says a thing that is true and useful and should not be overstated. She looked at all three of them, something warm settling in her expression. "I also want to say, I love that you're all here doing this. Being supportive. Trying to be informed."

She said it like she meant it, not like a policy. "I love an informed patient. I'll do everything I can to keep you that way."

A small pause. "And thanks for asking the hard questions. That part matters."

Then, to Maria: "Garcia? Maria Garcia? Lab order is ready at the front desk." Her name tag read NANI, Registered Nurse, Clinical Trial Coordinator.

Maria stood, tucked the card into her coat pocket, and went with her.

The question about the gatekeeper mutation was written on a notepad in Debby's handwriting, ready for the next appointment.

Next issue: Debby brings a question that has been building for 4 issues. And she asks it somewhere new.

Send this to someone who says all the right things with the wrong delivery. The information is correct. The words are clear. But the heart came after the facts. That's the only thing Cora changed.

This week's Plain Talk covers the same topic in plain language. Subscribe to get it in your inbox at RootToRx.com.

Want the full science? This issue's The Informed covers the T315I gatekeeper mutation, asciminib's STAMP mechanism, and the full citation tier breakdown for the daraxonrasib Phase 3 data. Read it at [INFORMED URL].

For educational purposes only. Nothing in this newsletter is medical advice. Talk to your doctor before making any health decision.

Instagram: instagram.com/roottorx | Facebook Lab: facebook.com/groups/theroottorxlab | Subscribe: RootToRx.com

228 Park Ave S, #29976, New York, NY 10003, United States

Reply

Avatar

or to participate

Keep Reading